Date: 2014-08-12 13:02:45

Immunology

Rheumatoid arthritis

Tofacitinib

Disease-modifying antirheumatic drug

Adalimumab

Leflunomide

Etanercept

Infliximab

Golimumab

Immunosuppressants

Pharmacology

Medicine

Xeljanz® (tofacitinib tablets – Pfizer) To Initiate a Coverage Review, Call[removed]OVERVIEW Xeljanz is an inhibitor of the Janus kinases (JAK) pathways approved for the treatment of adults with moderately to s

Document is deleted from original location.
Use the Download Button below to download from the Web Archive.

File Size: 111,95 KB